Cerus (NASDAQ: CERS) revenue
Cerus reported revenue of $233.8m for fiscal 2025, 16.1% more than in fiscal 2024 ($201.3m). Since fiscal 2016 its revenue has grown by 495.3%, an average growth of 21.9% a year.
Cerus has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2023, −0.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $233.8m | +16.1% | −$8.7m | −3.7% |
| 2024 | $201.3m | +7.8% | −$14.2m | −7.1% |
| 2023 | $186.8m | −0.8% | −$30.1m | −16.1% |
| 2022 | $188.3m | +18.1% | −$34.1m | −18.1% |
| 2021 | $159.5m | +39.6% | −$48.9m | −30.7% |
| 2020 | $114.2m | +21.8% | −$58.3m | −51.1% |
| 2019 | $93.8m | +23.3% | −$66.2m | −70.6% |
| 2018 | $76.1m | +48.2% | −$55.0m | −72.3% |
| 2017 | $51.3m | +30.7% | −$57.5m | −112.1% |
| 2016 | $39.3m | — | −$61.4m | −156.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Cerus revenue compared with its sector
By revenue for its latest fiscal year, Cerus ranks 241st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Cerus, 16.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 239th | Akebia Therapeutics | $236.2m | 47.5% |
| 240th | Anaptysbio | $234.6m | 157.0% |
| 241st | Cerus | $233.8m | 16.1% |
| 242nd | Puma Biotechnology | $228.4m | −0.9% |
| 243rd | Axogen | $225.2m | 20.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Cerus
- How much revenue did Cerus make in fiscal 2025?
- Cerus reported revenue of $233.8m for fiscal 2025, compared with $201.3m in fiscal 2024.
- How much has the revenue of Cerus grown?
- Between fiscal 2016 and fiscal 2025 it went from $39.3m to $233.8m: 495.3% more, an average growth of 21.9% a year.
- What was the best year for revenue at Cerus?
- Of its last 10 fiscal years, fiscal 2025, with $233.8m.
- Where does Cerus rank in its sector by revenue?
- It ranks 241st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Cerus come from?
- From the annual report (Form 10-K) that Cerus files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Cerus files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Cerus: the Cerus page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.